Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001578563-19-000028

Options or other derivatives

  • Director acquired 4,411 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Persson Magnus · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-09-30 Grant or award : show line 1 in the form Stock Option (Right to Buy) +4,411 $3.29 2029-09-30 4,411 4,411 D
Loading xslF345X03/primary_doc.xml…